Video interview with this patient with childhood asthma and ABPA. After persistent chest infections and continuous steroids and a bad productive cough, Aspergillus was cultured from sputum in 2002. After successfully taking itraconazole, the patient developed peripheral neuropathy (tingling and loss of sensation) in the hands. After stopping itraconazole – persistent chest infections requiring antibiotics and prednisolone were common. The patient at this point had a high IgE level and positive RAST tests. Voriconazole was then prescribed – which has successfully treated the aspergillus infection – no steroids are required and the cough is greatly reduced with the patient feeling well. However an unfortunate side effect of voriconazole has been a photosensitive rash on any exposed skin. Despite using complete sunscreen – the rash continues. The patient is continuing to take voriconazole.
Share this post
Latest News posts
Patients & Carers meeting November 2017
January 11, 2019
Patients & Carers meeting October 2017
January 11, 2019
Patients & Carers meeting September 2017
January 11, 2019
Patients & Carers meeting August 2017
January 11, 2019
Patients & Carers meeting July 2017
January 11, 2019
Patients & Carers meeting June 2017
January 11, 2019
Patients & Carers meeting May 2017
January 11, 2019
Patients & Carers meeting April 2017
January 11, 2019
Patients & Carers meeting March 2017
January 11, 2019
Patients & Carers meeting February 2017
January 11, 2019
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video